We are live on ! Find out more
EUDAW icon

EUDA Health Holdings Warrant

10 hedge funds and large institutions have $279K invested in EUDA Health Holdings Warrant in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 4.84%4.87% (+0.02%)

0% more funds holding

Funds holding: 1010 (0)

7% less capital invested

Capital invested by funds: $300K → $279K (-$20.3K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$683

EUDAW Hedge Fund Activity: Q2 2024 in Review

10 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q2 2024, worth a combined $279K — down 6.8% from $300K a quarter earlier.

Fund positioning in EUDAW was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $683. The largest seller was Hudson Bay Capital Management, cutting an estimated $829.

  • 10 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $279K of EUDA Health Holdings Warrant stock for Q2 2024, down 6.8% quarter-over-quarter.
  • 0 funds opened new EUDA Health Holdings Warrant positions in Q2 2024 and 0 closed out.
  • The largest EUDA Health Holdings Warrant buyer in Q2 2024 was Citadel Advisors, an estimated $683 added.
  • The largest EUDA Health Holdings Warrant seller in Q2 2024 was Hudson Bay Capital Management, an estimated $829 sold.

Based on aggregated 13F filings for Q2 2024.